Akebia Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Feb 24 | Sell€8,732 | Nicole Hadas | Individual | 5,974 | €1.46 | |
29 Feb 24 | Sell€12,659 | Michel Dahan | Individual | 8,661 | €1.46 | |
29 Feb 24 | Sell€68,069 | John Butler | Individual | 46,570 | €1.46 | |
29 Feb 24 | Sell€10,479 | Steven Burke | Individual | 7,169 | €1.46 | |
27 Feb 24 | Sell€52,852 | John Butler | Individual | 37,733 | €1.40 | |
27 Feb 24 | Sell€15,049 | Michel Dahan | Individual | 10,744 | €1.40 | |
01 Feb 24 | Sell€37,649 | Steven Burke | Individual | 24,311 | €1.55 | |
01 Feb 24 | Sell€71,994 | John Butler | Individual | 46,489 | €1.55 | |
25 May 23 | Sell€108,867 | Michel Dahan | Individual | 95,478 | €1.14 | |
25 May 23 | Sell€72,047 | Nicole Hadas | Individual | 63,186 | €1.14 | |
16 May 23 | Sell€62,506 | David Spellman | Individual | 63,567 | €0.98 | |
16 May 23 | Sell€62,506 | Steven Burke | Individual | 63,567 | €0.98 |
Insider Trading Volume
Insider Buying: AX9 insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,704 | 0.000814% |
Individual Insiders | 4,970,863 | 2.37% |
VC/PE Firms | 14,202,558 | 6.78% |
Institutions | 39,351,872 | 18.8% |
General Public | 150,845,278 | 72% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
14,202,558 | €18.1m | -12.4% | 30.5% | |||
7,607,472 | €9.7m | 1.15% | no data | |||
6,915,503 | €8.8m | -4.26% | 0.03% | |||
4,779,383 | €6.1m | 51.5% | 0.01% | |||
3,122,824 | €4.0m | 27.3% | no data | |||
2,599,987 | €3.3m | -14.8% | no data | |||
2,159,364 | €2.7m | 188% | no data | |||
2,002,561 | €2.5m | 0% | no data | |||
1,856,925 | €2.4m | 8.02% | 0.01% | |||
1,801,690 | €2.3m | 4.49% | no data | |||
1,467,810 | €1.9m | 11.1% | no data | |||
866,554 | €1.1m | -10.2% | no data | |||
790,483 | €1.0m | 0% | no data | |||
673,779 | €857.2k | 63.6% | no data | |||
620,319 | €789.2k | -0.61% | no data | |||
610,550 | €776.7k | -6.99% | no data | |||
579,490 | €737.2k | -9.18% | no data | |||
397,292 | €505.4k | 7.28% | no data | |||
342,840 | €436.2k | 26.5% | no data | |||
340,965 | €433.8k | 6.54% | no data | |||
310,368 | €394.9k | 2.73% | no data | |||
305,606 | €388.8k | 100% | no data | |||
257,173 | €327.2k | 112% | no data | |||
242,974 | €309.1k | 0% | no data | |||
200,000 | €254.4k | 0% | 0.01% |